Author： De Vry J. Schreiber R. de Beun R.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 177-178
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Animal and cellular models for hypolipidemic drugs
Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. :
Access to resources
Recommend
Animal models to evaluate anti‐atherosclerotic drugs
Fundamental & Clinical Pharmacology, Vol. 29, Iss. 4, 2015-08 ,pp. :
Serotonergic Drugs for Depression and Beyond
Current Drug Targets, Vol. 14, Iss. 5, 2013-05 ,pp. :
By Verheij Michel Veenvliet Jesse Groot Kormelink Tom Steenhof Maaike Cools Alexander
Psychopharmacology, Vol. 205, Iss. 3, 2009-08 ,pp. :
Serotonergic drugs and valvular heart disease
By Rothman Richard B Baumann Michael H
Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. :